Trial site
Madrid
- 29running trials
- 34closed trials
The trials here
What the 63 trials at this site are about, from their registry records.
- Conditions
- Lung cancer10 trials
- Chronic myeloid leukaemia8 trials
- Colorectal cancer7 trials
- Melanoma5 trials
- Coronary artery disease4 trials
- Multiple sclerosis4 trials
- Prostate cancer4 trials
- Childhood cancers3 trials
- Gastric and oesophageal cancer3 trials
- High blood pressure3 trials
- Metastatic breast cancer3 trials
- Myelodysplastic syndromes3 trials
- and 22 more
- Phase
- Phase 319 trials
- Phase 217 trials
- Phase 115 trials
- Phase 1/26 trials
- Phase 2/31 trial
- Phase 41 trial
- Status
- Completed19 trials
- Active, not recruiting16 trials
- Terminated15 trials
- Recruiting13 trials
- Lead sponsor
- Novartis Pharmaceuticals63 trials
Running trials
Recruiting
Recruiting
A Study to Estimate Secukinumab Retention Rate in Psoriasis Patients With MASLD
Recruiting
A Study to Evaluate the Efficacy of NIO752 in Participants With Progressive Supranuclear Palsy
Recruiting
Study of IEV407 as Single Agent or in Combination in Patients With Advanced HR+/HER2- Breast Cancer
Recruiting
Recruiting
Active, not recruiting
Recruiting
Study to Determine the Efficacy and Safety of Asciminib in Pediatric Patients With Ph+ CML-CP
Recruiting
Recruiting
Recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting
Phase I Study of [177Lu]Lu-NNS309 in Patients With Pancreatic, Lung, Breast and Colorectal Cancers
Active, not recruiting
Recruiting
Active, not recruiting
Active, not recruiting
Dose Optimization and Expansion Study of DFV890 in Adult Patients With Myeloid Diseases
Active, not recruiting
A Study of Inclisiran to Prevent Cardiovascular Events in High-risk Primary Prevention Patients.
Active, not recruiting
Active, not recruiting
Active, not recruiting
Study of JDQ443 in Patients With Advanced Solid Tumors Harboring the KRAS G12C Mutation
Active, not recruiting
Long-term Safety, Tolerability and Effectiveness Study of Ofatumumab in Patients With Relapsing MS
Active, not recruiting
Active, not recruiting
Active, not recruiting
Active, not recruiting
Recruiting at the same time
How many trials recruit for the same indication here at once. A count, not a rating.
- Prostate cancer3 recruiting
- Childhood cancers1 recruiting
- Chronic myeloid leukaemia1 recruiting
- Colorectal cancer1 recruiting
- Fatty liver disease (MASLD/MASH)1 recruiting
- IgA nephropathy1 recruiting
- Lung cancer1 recruiting
- Metastatic breast cancer1 recruiting
- Multiple sclerosis1 recruiting
- Pancreatic cancer1 recruiting
- Psoriasis1 recruiting
- Triple-negative breast cancer1 recruiting
Closed trials
Completed
Completed
Terminated
A Phase I Study of [177Lu]Lu-FF58 in Patients With Advanced Solid Tumors.
Completed
Terminated
Extension Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension Participants
Completed
Terminated
Terminated
Study of Efficacy and Safety of LTP001 in Pulmonary Arterial Hypertension
Terminated
Completed
Terminated
Completed
Terminated
Terminated
Terminated
A Phase I/Ib Study of NIZ985 Alone and in Combination With Spartalizumab
Completed
Terminated
Platform Study of Novel Ruxolitinib Combinations in Myelofibrosis Patients
Terminated
Completed
Completed
Completed
Completed
Study of Dose Confirmation and Safety of Crizanlizumab in Pediatric Sickle Cell Disease Patients
Completed
Completed
Terminated
Dose Finding Study of TNO155 in Adult Patients With Advanced Solid Tumors
Terminated
A Phase Ib Study of LXH254-centric Combinations in NSCLC or Melanoma
Terminated
Terminated
Safety and Efficacy of MAK683 in Adult Patients With Advanced Malignancies
Completed
Completed
Completed
Nilotinib Treatment-free Remission Study in CML (Chronic Myeloid Leukemia) Patients
Completed
Treatment-free Remission After Achieving Sustained MR4.5 on Nilotinib (ENESTop)
Completed
A Study of LGK974 in Patients With Malignancies Dependent on Wnt Ligands
Completed
Site data: ClinicalTrials.govUpdated 18 Nov 2026